ArticlePharmacology research & perspectives2024

Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience.

Sandra Fontanals et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.